Evidence map›Paper›PMID 41147417›Full record

ArticleJournal of the American Heart Association2025

A Multiomics Approach to Defining Target-Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort.

Kalyani Ananthamohan, Tammy M Brady, Mohammed Arif, Stephen R Daniels, Bonita Falkner, Michael Ferguson, Joseph T Flynn, Coral Hanevold, Stephen R Hooper, Julie R Ingelfinger and 12 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Integrating causal human genetics andFrontiers in molecular biosciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Kalyani AnanthamohanDepartment of Cellular and Molecular Medicine, Sarver Heart Center University of Arizona College of Medicine Tucson AZ USA.
Tammy M BradyDepartment of Pediatrics, Division of Nephrology Johns Hopkins University School of Medicine Baltimore MD USA.
Mohammed ArifDepartment of Internal Medicine, Division of Cardiovascular Health and Diseases, Center for Cardiovascular Research University of Cincinnati College of Medicine Cincinnati OH USA.
Stephen R DanielsDepartment of Pediatrics University of Colorado School of Medicine Aurora CO USA.
Bonita FalknerDepartments of Medicine and Pediatrics Thomas Jefferson University Philadelphia PA USA.
Michael FergusonDivision of Nephrology Boston Children's Hospital Boston MA USA.
Joseph T FlynnDepartment of Pediatrics, University of Washington School of Medicine, Division of Nephrology Seattle Children's Hospital Seattle WA USA.
Coral HanevoldDepartment of Pediatrics University of Washington School of Medicine Seattle WA USA.
Stephen R HooperDepartment of Health Sciences, School of Medicine, Department of Health Sciences University of North Carolina at Chapel Hill Chapel Hill NC USA.
Julie R IngelfingerDepartment of Pediatrics, Harvard Medical School, Mass General Hospital for Children at Massachusetts General Brigham Boston MA USA.
Marc LandeDepartment of Pediatrics University of Rochester Medical Center Rochester NY USA.
Lisa J MartinDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA.
Kevin E MeyersDivision of Nephrology and Hypertension Children's Hospital of Philadelphia Philadelphia PA USA.
Mark MitsnefesDivision of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA.
Bernard RosnerChanning Division of Network Medicine Harvard University Cambridge MA USA.
Joshua A SamuelsPediatric Nephrology & Hypertension, McGovern Medical School University of Texas Houston TX USA.
Gina KuffelDepartment of Public Health Sciences Loyola University Chicago Maywood IL USA.
Michael J ZillioxDepartment of Public Health Sciences Loyola University Chicago Maywood IL USA.
Qin M ChenDepartment of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy University of Arizona Tucson AZ USA.
Richard C BeckerDepartment of Internal Medicine, Division of Cardiovascular Health and Diseases, Center for Cardiovascular Research University of Cincinnati College of Medicine Cincinnati OH USA.
Elaine M UrbinaThe Heart Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA.
Sakthivel SadayappanDepartment of Cellular and Molecular Medicine, Sarver Heart Center University of Arizona College of Medicine Tucson AZ USA.

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS · 1995 to 2026
$32.6M
Fast myosin binding protein-C and cardiac contractility in heart failureR01HL105826 · NHLBI · UNIVERSITY OF CINCINNATI · PI SADAYAPPAN, SAKTHIVEL · 2011 to 2025
$4.5M
Skeletal muscle sarcomere function in health and diseaseR01AR079477 · NIAMS · UNIVERSITY OF MINNESOTA · PI JOSEPH Mark METZGER · 2022 to 2026
$2.6M
Skeletal Myosin-Binding Protein C Regulation and Structural DynamicsR01AR079435 · NIAMS · UNIVERSITY OF ARIZONA · PI Brett A Colson · 2022 to 2026
$2.4M
Slow myosin binding protein-C in skeletal muscle physiologyR01AR078001 · NIAMS · UNIVERSITY OF CINCINNATI · PI SADAYAPPAN, SAKTHIVEL · 2020 to 2023
$1.8M
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injuryR01HL143490 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2019 to 2022
$1.6M
Molecular mechanism of hypertrophic cardiomyopathy in populations of South Asian descendantsR01HL130356 · NHLBI · UNIVERSITY OF CINCINNATI · PI SADAYAPPAN, SAKTHIVEL · 2016 to 2019
$1.6M
NHLBI NIH HHS R01 HL105826NHLBI NIH HHS R01 HL130356NHLBI NIH HHS R01 HL143490NIAMS NIH HHS R01 AR078001NIAMS NIH HHS R01 AR079435NIAMS NIH HHS R01 AR079477NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

backgroundPrimary hypertension in childhood tracks into adulthood and is associated with increased cardiovascular risk. Studies conducted in individuals aged <18 years, an age group without many of the confounding comorbid cardiovascular disease risk factors in adults, provide an opportunity to explore early cardiovascular target-organ injury.

methodsYouths (n=132, mean age, 15.8 years) were stratified by blood pressure (BP) as low-BP, mid-BP, and high-BP and by left ventricular mass index as low-and high left ventricular mass index. Systemic circulating RNA, microRNA, and methylation profiles in peripheral blood mononuclear cells and deep proteome profiles in serum were determined using high-throughput sequencing techniques. In vitro cell culture experiments assessed angiotensin II- and microRNA-mediated Vash1 (vasohibin-1 protein) regulation and Vash1-mediated hypertrophic response.

resultsIn high-BP youths, transcriptomics analysis identified 7 differentially expressed genes, including elevated

conclusionsThe integration of multiomics data in this unique pediatric population during the early phase of high BP provides evidence of molecular changes that reveal both potential drug targets and strategies for ameliorating BP-mediated cardiovascular target-organ injury.

Indexed as

Blood PressureHypertensionAdolescentAngiotensin IICell Cycle ProteinsChildFemaleGene Expression ProfilingHumansMaleMicroRNAsMultiomicsProteomicsTranscriptomeAngiotensin IICell Cycle ProteinsMicroRNAsadolescentshyaluronidase1hypertensiontarget‐organ injuryvasohibin‐1

Identifiers

PMID41147417
PMCPMC12684800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.